Abstract
Conclusion
Our novel murine arteriovenous fistula model, which incorporates a clinically relevant configuration of the anastomosis, displays similar features that are characteristic of failing human fistulas. Moreover, our findings suggest that both coagulation and inflammation could potentially play an important role in the formation of intimal hyperplasia and subsequent arteriovenous fistula failure. Near infrared fluoroscopy proved to be a suitable alternative for conventional imaging techniques. We conclude that this murine AVF-model is a valuable addition to the AVF animal model arsenal.
Clinical relevance
The autologous arteriovenous fistula is considered to be the preferred choice of vascular access in hemodialysis. However, this type of vascular access suffers from a high failure rate of which the exact pathophysiology is poorly understood. The use of a clinically relevant murine model provides us with a tool to unravel the pathophysiology and also to develop new therapeutic strategies that can improve the patency of the arteriovenous fistula in hemodialysis patients.
Introduction
A durable vascular access is of vital importance for patients on chronic hemodialysis. In view of their superior patency rates, the construction of native arteriovenous fistulas (AVF) is currently the preferred choice for vascular access. However, the utility of AVFs is hampered by two distinct causes of failure: (1) an initial failure to mature; and (2) the later development of stenotic lesions in the venous outflow tract. The exact pathophysiology that results in maturation failure is unclear although both intimal hyperplasia (IH) and impaired outward remodelling (OR) seem to contribute 1 . Various studies report poor one-year primary patency rates of AVFs not exceeding 60-65% [2] [3] [4] .
To date, numerous animal models [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] have been designed to study AVF failure. While large animals such as pigs are more suitable for intervention studies, murine models have the greatest potential to gain more insight in the molecular mechanisms underlying this pathologic process due to the availability of transgenic mice.
In previous studies, two groups have described a murine AVF model in which the fistula was constructed in an end-to-end manner 7, 17 . In 2006, an improved model was introduced by Castier et al. 5, 18 where the end of the common carotid artery is connected to the side of the external jugular vein. However, in hemodialysis patients, AVFs are usually constructed by anastomosing the end of a vein to the side of an artery. The exact configuration of the AVF is crucial since it determines the hemodynamic profile 19 , an important contributor to endothelial dysfunction and subsequent development of IH [20] [21] [22] . Therefore, incorporating an AVF configuration resembling the human situation is preferable. In the present study, we developed a novel murine model with an identical anatomical configuration as utilized in humans. In our analysis, we focused on outward remodeling as well as the formation of IH in the venous outflow tract.
Material and Methods

Animals and study design
The Institutional Committee for Animal Welfare at the LUMC approved all experiments.
Forty-five male C57bl6 mice (Charles River) aged 8-13 weeks were used. Unilateral AVFs were created in an end-to-side manner between the dorsomedial branch of the external jugular vein and the common carotid artery. The animals were sacrificed at days 7, 14 and 28 after the surgical procedure. Identical veins of unoperated mice served as controls.
Anesthesia, analgesia and anticoagulant therapy
At the start of the procedure, animals were injected subcutaneously with buprenorphin (0.1 mg/kg) (MSD, Whitehouse Station, NJ, USA) and 0.5 mL saline. Isoflurane inhalation anesthesia with oxygen (40%) enriched air was used, with isoflurane concentrations of 4% for induction and 1.5% for maintenance. To prevent acute AVF thrombosis, acetylsalicylic acid (Sigma, St Louis, MO, USA) dosed at 30 mg/kg was dissolved in drinking water. However, this approach was not successful as it caused severe hemorrhage at the anastomosis. As an alternative, heparin was administered intravenously at a dose of 0.2 IU/gram bodyweight (LEO Pharma, Ballerup, Denmark).
Surgical procedure
After anesthetizing the animal, eyes were covered with an ointment (Oculentum simplex, Pharmachemie BV, Haarlem, The Netherlands) and the surgical area was shaved. Next, the animal was fixed in a supine position on a heating blanket. The skin was disinfected and a ventral midline incision was made in the neck under a dissecting microscope (M80, Leica, Wetzlar, Germany). After dissecting the dorsomedial distal branch of the right external jugular vein, a vascular clamp (S&T, Neuhausen, Switzerland) was placed proximally and a 10.0 ligature (BBraun, Melsungen, Germany) was placed distally followed by transection of the vein just proximal from the ligature. (Fig 1, A-E) The vein was then rinsed with saline containing 100 IU/ mL heparin. The right sternocleidomastoid muscle was then dissected and ligated proximally and distally with a 6.0 suture thread (BBraun, Melsungen, Germany). The muscle was then transsected between the two ligations with a heat cauterizer (Fine Science Tools, Heidelberg, Germany). Next, the right common carotid artery was dissected and clamped, followed by an incision of approximately 1.0 mm longitudinally with micro-scissors (Fine Science Tools, Heidelberg, Germany). Subsequently, the carotid artery was rinsed with heparin (100 IU/mL), whereupon the end of the vein was anastomized to the side of the artery using 10.0 interrupted sutures (BBraun, Melsungen, Germany). Heparin (0.2 IU/gram bodyweight) was injected intravenously halfway during suturing. After completion of the anastomosis, the remaining clamps were removed and patency was assessed. The skin was closed with a 6.0 running suture suture (BBraun, Melsungen, Germany). A more detailed description is available in the online supplement.
Following completion of the surgery 0.5 mL of saline was injected subcutaneously and the animals were kept warm until full recovery. A peroperative patent AVF, followed by a complete recovery from the anesthesia, was considered a surgical success. 
Near-infrared fluorescence imaging
To assess direct postoperative AVF patency and at the time of sacrifice (day 14 or day 28), near infrared fluorescence (NIRF) imaging was used as previously described 23 24 . 
Morphometric analysis
A histochemical staining with hematoxylin, phloxin and saffron (HPS) was used for a morphological overview. Fibrin deposition was assessed by using a Movat pentachrome staining.
Morphometric analysis was performed on Weigert's elastin stained sections. All venous sections were analyzed using quantitative imaging software (Qwin, Leica, Wetzlar, Germany).
The intimal area was calculated by subtracting the luminal area from the area within the internal elastic lamina (IEL). The circumference of the vessel was determined by the length of the IEL (Fig 2, A) . The percentage stenosis was defined as the intimal area divided by the intimal area plus the lumen area (intima/(intima+lumen) X 100). AVFs were defined patent histologically, when the maximum stenosis percentage in all included venous sections was ≤ 95%. Additionally, the venous sections were divided in 4 equal segments of 300 µm (A-D)
by grouping 2 consecutive slides starting from the area closest to the anastomosis (Fig 3, C) .
Results are expressed as mean ± standard error of the mean. 
Collagen quantification
Collagen content was determined in sirius red stained sections using quantitative imaging software (Qwin, Leica, Wetzlar, Germany). This was measured in the whole vessel and was expressed as total positive surface area (µm2) and as positive area divided by the total vessel area (%).
Immunohistochemical analysis
Serial 
Statistical analysis
Results are expressed as mean ± standard error of the mean. Comparison between the time points was performed by one-way ANOVA followed by a Tukey HSD test. Differences were considered statistically significant at a value of P < .05. 
Figure 3. Quantification of outward remodeling (OR) and intimal hyperplasia (IH). (A)
, OR was present in the first 14 days after arteriovenous fistula (AVF) creation. (B), IH increased progressively in time, whereas the luminal area only increased in the first 14 days after AVF placement due to a reduction in OR after this time point. Furthermore, the increase in IH between consecutive time points was significant between days 14 and 28. (C), The venous outflow tract was divided in four equal segments of 300 μm (A-D) and shows that the maximum IH (shaded area) was located at the site closest to the anastomosis. OR at days (D) 7, (E) 14, and (F) 28 and luminal area at days (G) 7, (H) 14, and (I) 28 were not differently distributed in the vein. At days 14 and 28, IH was the highest in the first 600 μm. (J), The total amount of collagen increased in time. (K), However, the amount of collagen divided by the total vessel area remained the same between the control and arterialized vein. *P < .05 compared with control. **P < .05 compared with the previous time point. Mean data are presented with the standard error of the mean (error bars).
Results
Surgical outcome
In total, 45 mice were operated and in 30 mice the surgical procedure was successful (67%).
The main cause of failure was hemorrhage (60%), followed by acute thrombosis (27%) and anesthesia related death (13%). In the group where the surgical intervention was successful, 3 mice died post-operatively of unknown causes and 1 mouse developed a wound abscess.
These 4 mice were excluded from the study. The remaining 26 mice were sacrificed at days 7 (8 mice), 14 (10 mice) and 28 (8 mice) after surgery. Eleven animals without AVF surgery served as control. The average time of the surgical procedure was 60 minutes.
Patency
Patency of the AVF was assessed visually using the dissecting microscope at time of sacrifice and was confirmed histologically. This resulted in patency rates of 88%, 90% and 50% at days 7, 14 and 28, respectively. In addition, the patency was assessed in 10 mice by NIRF. As shown 
Morphometric analysis
For the quantification of OR and IH, only patent AVFs were included in the analysis (7, 8 and 4 mice for 7, 14 and 28 days of follow-up, respectively).
Outward remodeling
The venous circumference at days 14 (2.36 ± 0.15 mm) and 28 (2.45 ± 0.24 mm) was higher compared to that of the unoperated control mice (1.33 ± 0.30 mm; P = .01 and P= .037, respectively). The highest increase in mean venous circumference (1.4-fold) was observed within 7 days after surgery (1.33 ± 0.30 mm vs 1.82 ± 0.07 mm; P = .443). Between days 7 and 14, a 1.3-fold increase was observed (P = .397), whereas no increase in venous circumference was observed from days 14 to 28 (P = .996). (Fig 3, A) .
No difference in OR was observed between various sections of the AVF (Fig 3, D-F) . Of note, the venous circumference of the occluded AVFs (1.69 ± 0.2 mm) at day 28 was smaller when compared to patent AVF (2.45 ± 0.2 mm) at the same time point. In all AVFs, we observed fragmentation of the IEL in the venous outflow tract (Fig 2, B) .
Intimal hyperplasia and luminal area
Already 7 days after surgery, we observed intimal hyperplasia (60138 ± 23626 µm 2 ) in the venous outflow tract (Fig 5, B-D) . This area further increased at days 14 and 28 (115090 ± 22594 µm 2 and 234619 ± 47828 µm 2 , respectively) and was significantly higher as compared to control mice (2368 ± 1056 µm 2 ; P = .001 and P <.001). (Fig 3, B) . Detailed analysis of the various sections within the venous outflow tract revealed that IH was most prominent in the first 600 µm from the anastomosis (Fig 3, G-I ) as compared to the control veins (P= .294). Between days 7 and 14, a 2-fold increase in lumen area was observed (P= .082). At day 28 the luminal area of the patent AVFs decreased with 5% compared to day 14 (P= .996) (Fig 3, B) .
The mean stenosis at days 7, 14 and 28 were 30%, 38% and 59%, respectively. Seven days after surgery, the highest percentage of stenosis was observed in the first 300 μm from the anastomosis (segment A). At days 14 and 28 after surgery, the percentage stenosis was the highest in segment A and B (data not shown 
Composition of intimal hyperplasia
Histological analysis revealed a dynamic composition of the intimal lesions. Starting from day 7 the intimal lesion consisted mainly of an acellular fibrin-rich layer, consistent with a focal adherent thrombus (Fig 5, B ,F,N-P). Concomitant with increased lesion size at later time points (day 14 and 28), progressive cellular density was observed (Fig 5, F-H) . The majority of cells within the intima were α-sma-positive (Fig 6, B-D) . Analysis of CD45-stained sections demonstrated the presence of leukocytes, mainly in the adventitia and outer circumference of the vessel wall at all time points and in the intima starting at day 14 (Fig 6, F-H) . The endothelial layer was disrupted at all time points, although CD31(+) cells did increase in time.
Furthermore, starting from day 7, an increased density of adventitial capillaries was observed (Fig 6, J-L) .
Quantification of collagen content in the venous outflow tract revealed a time-dependent increase in absolute collagen content (Fig 3, J-K and Fig 5, J-L) . However, no differences in collagen-positive area were observed between the control group and all time points were expressed as a percentage of the total vessel area. Thus, the relative contribution of collagen in the total vessel composition remained stable.
Discussion
In the present study, we describe a novel murine model of AVF failure in which the AVF configuration resembles the human situation (venous end to arterial side). We observed that the venous outflow tract of AVFs is characterized by OR in the first 14 days. Furthermore, we hypothesize that focal adherent thrombi appear to serve as fertile soil for the formation of progressive α-sma positive intimal lesions ultimately leading to a 50% loss of patency at 28 days after surgery.
Anticoagulant therapy was necessary for creating a patent AVF and finding the correct balance between acute thrombosis and hemorrhage proved to be of crucial importance. Importantly, we observed a very high incidence 69% of bleeding complications when using acetylsalicylic acid.
Therefore, as an alternative, we administered a single dose of heparin which was effective in preventing acute thrombosis. Using our protocol with heparin, we observed early thrombosis and bleeding complications in 3% and 7% of the mice, respectively.
Outward remodeling
Although IH is widely considered to be the most important determinant of AVF failure, the functionality of the AVF is generally determined by the luminal area, which is defined by the net result of OR and IH formation. To the best of our knowledge, we are the first to quantify OR by measuring the circumference of the venous outflow tract in murine AVF. Studies in rats and mice have revealed that OR is induced by the increase in flow that evokes an adaptive response of the vessel in which the luminal diameter increases in attempt to reduce wall shear stress to pre-AVF levels 8, 25, 26 . In our study, we observed a 1.4-fold increase in venous circumference within 7 days after AVF placement. Unfortunately, data on wall shear stress could not be collected in this study. The decrease in OR at later time points could be the result of the partial normalization of shear stress levels as previously observed in murine 26 and human 27 AVF studies. Furthermore, we observed fragmentation of the IEL of the venous outflow tract, a phenomenon that has been described in previous studies [28] [29] [30] . This effect is likely driven by flow-induced matrix metalloproteinase (MMP)-2 and MMP-9 activation, a process that is essential in facilitating outward remodeling 28, 29 . In keeping with this notion, serum levels of MMP-2 have been shown to be significantly higher in patients with matured AVFs as compared to non-matured AVFs 31 .
We observed a smaller venous circumference in the occluded AVFs at 4 weeks after surgery.
The latter might suggests that the cause of AVF failure in these cases could potentially be the result of impaired OR. However, these data should be interpreted with caution since we cannot exclude the possibility that the circumference decreased upon occlusion of the vessel.
Intimal hyperplasia formation
In failing human AVFs, IH is designated as one of the main contributors in the pathophysiology and is typically located in the juxta-anastomotic area of the venous outflow tract 32, 33 . In our study, progressive IH developed in this same region of the AVF, illustrating the resemblance to failing human fistulas.
Interestingly, we observed a remarkable pattern in the development of IH not previously described in AVF studies. In our murine AVFs, IH appears to commence with the focal adherence of thrombi. In the following weeks, these lesions showed progressive cellularity, culminating in a high cellular density at 28 days after surgery. At this time, intimal lesions possessed the hallmarks of classic IH of failed human AVFs, as evidenced by the presence of high numbers of α-sma(+) cells 32, 34 .
Thus far, IH is considered primarily to be the direct result of migrating and proliferating VSMCs, and that thrombus formation in the early phase after surgery would be considered a separate entity 5, 11, 13, 35 . Although the venous morphology in the early phase after AVF surgery has not been described in great detail in humans, the sequence of events in the development of IH in our study does resemble the pathophysiology of intimal lesions after (arterial) angioplasty and in vein grafts 36, 37 . Furthermore, Castier et al. also showed partly acellular lesions in the venous outflow tract of murine AVF 5 . The adherence of small (platelet and fibrin-rich) thrombi to the vessel wall most likely results from endothelial denudation and the subsequent exposure of the subendothelial matrix leading to platelet adhesion and activation 36, 38, 39 . Indeed, we observed marked endothelial denudation in the venous outflow tract in the first 7 days after surgery, a phenomenon that also was observed in previous animal studies of AVF failure 8, 11 .
This observation might suggests that anticoagulatory interventions could be an eligible strategy to inhibit intimal hyperplasia. Previous studies in a murine vascular endothelial injury model indeed revealed reduced IH upon treatment with human soluble CD39, an inhibitor of ADPmediated platelet activation 40 . In contrast, a randomized clinical controlled trial by Dember et al. showed no significant effect on AVF maturation, despite a reduction in incidence of early thrombosis in patients treated with clopidogrel 41 . In our opinion, the limited effect of systemic antiplatelet therapy on AVF maturation in humans does not necessarily preclude a contributing role of platelets in local development of IH in AVF.
Role of inflammation in vascular adaptation in arteriovenous fistulas
The inflammatory response is a crucial process involved in vascular injury and is linked to development of IH 37, 39, 42 . 
45
. However, the role of inflammation in outward remodeling in the AVF has gained little attention. Future experiments using anti-inflammatory therapeutic agents could aid in the elucidation of the contribution of inflammation in AVF remodeling.
Animal models
In concordance with other rodent AVF models 5, 7, 8, [11] [12] [13] , we observed rapid development of IH. Furthermore, as previously described in AVF studies in rats 8, marked venous OR was observed in the first 14 days following surgery. As a result of this venous OR, we observed an increase in luminal area in the first 14 days, whereas Castier et al. described a decrease in luminal area from the first week after AVF creation 5 . In Castier's study however, the arterial rather than the venous segment of the AVF was analyzed. Together with the difference in AVF configuration, this might explain the observed difference in luminal area since previous studies in rats have revealed that arterial OR is less prominent than venous OR. 8 However, this explanation remains speculative since no data on OR were reported by Castier et al.
Near infrared fluorescence imaging
We were unable to visualize the AVF with conventional techniques such as ultrasonography (US) and magnetic resonance imaging (MRI). Therefore, we utilized NIRF technology, which proved to be a quick and accurate method to assess the patency of murine AVFs.
Study limitation
Although animal models are useful in gaining insight into the pathophysiology of various human diseases, we should remain cautious in the interpretation and extrapolation, as the pathology in animals does not necessarily mimic to that of humans.
A multitude of risk factors, including the uremic milieu and the hemodialysis procedure itself are likely to contribute to premature vascular diseases 46, 47 . Uremia can play a major role in this regard, and more specifically can directly lead to venous IH in end stage renal disease patients prior to hemodialysis access surgery 48 . For future studies, incorporation of chronic renal failure in mice as described by Kokubo et al. 35 will be considered.
The complex microsurgical procedure remains a challengeable one that requires a skilled surgeon. However, the surgical difficulty is comparable to the existing murine AVF model as described by Castier 5 . Importantly, sufficient training has led to a surgical success rate during ongoing experimental studies of 97%.
In conclusion, we describe a novel murine AVF model with a similar configuration as is used most frequently in humans. This end-to-side configuration, while providing a more accurate reflection of human AVF pathophysiology, can also yield novel insight into this process by being effectively applied in a myriad of transgenic animals. In view of the different proposed mechanisms that are involved in venous remodeling in the AVF, disabling genes that play an important role in coagulation, inflammation and VSMC biology can help us to elucidate the complex pathophysiology of AVF failure. The obtained knowledge from these studies will hopefully result in the development of new therapeutic strategies that improve the patency of AVFs in patients that require hemodialysis.
Supplemental Data
Surgical procedure
After anesthetizing the mice, we covered the eyes with a sterile ointment and shaved the surgical area. Next, the animal was fixed in a supine position on a heating blanket. The skin was then disinfected with ethanol and a ventral midline incision was made in the neck under a dissecting microscope (M80, Leica, Wetzlar, Germany). After dissecting the dorsomedial distal branch of the right external jugular vein, a vascular clamp (B1-V, S&T, Neuhausen, Switzerland) was placed proximally and a 10.0 ligature (BBraun, Melsungen, Germany) was placed distally followed by transection of the vein just proximal from the ligature. (Fig 1, A-E) The vein was then rinsed with saline containing 100 IU/ml heparin. The right sternocleidomastoid muscle was then resected with a cauterizer (Fine Science Tools, Heidelberg, Germany). Next, the right common carotid artery was dissected and clamped, followed by an incision with a micro-scissor (Fine Science Tools, Heidelberg, Germany) of approximately 1.0 mm longitudinally. Subsequently, the carotid artery was rinsed with saline containing 100 IU/ml heparin, whereupon the end of the vein was anastomized to the side of the artery using 10.0 interrupted sutures. The first two interrupted sutures were inserted at the twelve-and six o' clock position of the vein and at the ends of the incision in the artery, providing mild tissue tension and a good starting position by dividing the suture area of the vein in two even portions. Tension was then also applied longitudinally using a 6.0 suture thread (BBraun, Melsungen, Germany) that was placed below the vein, and was followed by placing interrupted 10.0 sutures at the exposed half of the anastomosis. Next, heparin was injected intravenously in the femoral vein at a dose of 0.2 IU/gram bodyweight. The rear unexposed part of the anastomosis was then exposed by a 180 degrees axial rotation of the arterial clamps and the partly anastomosed vein with the help of a suture thread that now is placed above the vein and below the artery. The venous clamp was removed during the rotational procedure. After completion of the anastomosis, the remaining arterial clamps were removed starting with the distal clamp. After confirming the patency of the AVF, the skin was closed with a 6.0 running suture (BBraun, Melsungen, Germany).
Immunohistochemistry
For immunohistochemical stainings, deparaffinization and hydration was followed by a treatment with 1% hydrogen peroxide and 5% bovine serum albumine in order to block the endogenous peroxidase and aspecific binding sites respectively. Antigen retrieval in the anti-CD31 and CD45 staining consisted of a treatment with 0.1% trypsin (Sigma-Aldrich, St. Louis, MO, USA) for 30 minutes at 37 degrees Celsius.
Incubation of the primary antibodies was performed overnight at room temperature.
Subsequently, sections were incubated at room temperature for 1 hour with HRP labeled antibodies against: mouse IgG (Dako, Glostrup, Denmark) in the α-smooth muscle actin staining at 1:1000 dilution and rabbit IgG (Envision, Dako, Glostrup, Denmark) in the staining against CD31 Biotinylated anti rat antibody (Vector laboratories, Burlingame, CA, USA) was used in the stainings against CD45, followed by a treatment with a 0.2 % streptavidin-AB complex (Dako, Glostrup, Denmark) for 30 minutes at room temperature. Immunoreactive tissue was then developed by using a DAB peroxidase substrate kit (Dako, Glostrup, Denmark).
Sections were counterstained with hematoxylin.
Near infrared fluoroscopy
Video 1
Visualization of a patent arteriovenous fistula directly after creation using near infrared fluorescence imaging. Two hundred µL of indocyanine green adsorbed to human serum albumin (500µM) was injected intravenously in the femoral vein. The fluorescent signal signal of indocyanine green was pseudo-colored green and merged with the color video.
Video 2
Visualization of a patent arteriovenous fistula 28 days after creation using near infrared fluorescence imaging. Two hundred µL of indocyanine green adsorbed to human serum albumin (500µM) was injected intravenously in the femoral vein seconds after the start of the recording. The fluorescent signal signal of indocyanine green was pseudo-colored green and merged with the color video. The video shows direct antegrade filling of the venous outflow tract demonstrating a patent arteriovenous fistula.
